PA
BSTC

Perceptive Advisors’s BioSpecifics Technologies Corp. BSTC Stock Holding History

Perceptive Advisors’s Portfolio BSTC Stock Details BSTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-6,065
Closed -$234K – 186
2014
Q4 		$234K Buy
+6,065
New +$231K 0.02% 135
2014
Q3 		– Sell
-3,700
Closed -$100K – 147
2014
Q2 		$100K Buy
+3,700
New +$96.4K 0.01% 109

Other funds holding BSTC

Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NC
Northpointe Capital Bloomfield Hills, Michigan $258M AUM 1.97% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

Perceptive Advisors's BSTC Position: Q1 2015 in Review

Perceptive Advisors sold out of BioSpecifics Technologies Corp. (BSTC) in Q1 2015, closing a stake of 6,065 shares — an estimated $234K sold.

Perceptive Advisors first reported a position in BSTC in Q2 2014 and held it in 2 quarters. The position peaked at $234K in Q4 2014. 79 funds tracked by Wall St. Rank hold BSTC as of Q1 2015.

  • Perceptive Advisors reported no remaining BioSpecifics Technologies Corp. position as of Q1 2015 after selling out during the quarter.
  • Perceptive Advisors sold 6,065 BioSpecifics Technologies Corp. shares in Q1 2015, an estimated $234K.
  • Perceptive Advisors first reported a position in BioSpecifics Technologies Corp. in Q2 2014 and held it in 2 quarters.
  • Perceptive Advisors's BioSpecifics Technologies Corp. position peaked at $234K in Q4 2014.
  • 79 funds tracked by Wall St. Rank held BioSpecifics Technologies Corp. as of Q1 2015.

Based on Perceptive Advisors's 13F filing for Q1 2015, filed 15 May 2015.